High Accuracy Drug-Target Protein Interaction Prediction Method based on DBN

Drugs may have multiple drug targets, and the most of targets are composed of different proteins. Therefore, the study of drug-target interaction (DTI) prediction has important meaning in drug repositioning, drug development time shortening and the cost of drug research and development reducing. Most of the existing methods are based on shallow learning model. The prediction accuracy is not high. In this paper, we proposed a deep belief network-based DTI prediction algorithm: we extracted extended connected fingerprint of the drug from the molecular structure. And then, we extracted the structure characteristics of the three peptide of the protein from the amino acid sequence of the protein. At last, we train the deep belief network by the characteristic vector extracted from drugs and proteins. In our proposed method, we fully use of the characteristics in the deep learning network and integrate the empirical feature selection into the deep belief network. Base on the public data set and compared with the state-of-the-art approaches, the experimental results show that our method outperforms the other algorithms in massive data sets.

[1]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[2]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[3]  M. Dickson,et al.  Key factors in the rising cost of new drug discovery and development , 2004, Nature Reviews Drug Discovery.

[4]  Dong-Sheng Cao,et al.  propy: a tool to generate various modes of Chou's PseAAC , 2013, Bioinform..

[5]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[6]  Minoru Kanehisa,et al.  The KEGG database. , 2002, Novartis Foundation symposium.

[7]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[8]  Yuhao Wang,et al.  Predicting drug-target interactions using restricted Boltzmann machines , 2013, Bioinform..

[9]  J. Drews Drug discovery: a historical perspective. , 2000, Science.

[10]  Chang Liu,et al.  Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..

[11]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[12]  Yoshihiro Yamanishi,et al.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..

[13]  Hao Ding,et al.  Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..

[14]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[15]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[16]  J. Gies,et al.  Drugs and their molecular targets: an updated overview , 2008, Fundamental & clinical pharmacology.

[17]  P. Bork,et al.  Drug discovery in the age of systems biology: the rise of computational approaches for data integration. , 2012, Current opinion in biotechnology.

[18]  Hailin Chen,et al.  A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks , 2013, PloS one.